Clinical Trial Update: Vitamin A Palmitate Supplementation in Patients With Reticular Pseudodrusen (RPD) and Delayed Dark Adaptation [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 study evaluating vitamin A palmitate supplementation in patients with Reticular Pseudodrusen and delayed dark adaptation, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Reticular Pseudodrusen

Drugs mentioned

• Vitamin A Palmitate (retinyl palmitate)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Reticular Pseudodrusen (RPD), Age-Related Macular Degeneration | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2024-07-03